Showing results (1861-1870 of 1,914) with videos related to

Sort By:
Pageof 192
Scientific Reports|December 21, 2016
A nationwide cross-sectional survey on prevalence, management and pharmacoepidemiology patterns on hypertension in Chinese patients with chronic kidney diseaseWen Zhang, Wei Shi, Zhangsuo Liu, et al.
Bioorganic & Medicinal Chemistry Letters|December 30, 2006
3-[2-((2S)-2-cyano-pyrrolidin-1-yl)-2-oxo-ethylamino]-3-methyl-butyramide analogues as selective DPP-IV inhibitors for the treatment of type-II diabetesMohane Selvaraj Coumar, Chung-Nien Chang, Chiung-Tong Chen, et al.
Medrxiv : the Preprint Server for Health Sciences|November 14, 2023
Improving imputation quality in Samoans through the integration of population-specific sequences into existing reference panelsJenna C Carlson, Mohanraj Krishnan, Shuwei Liu, et al.
Journal of Pediatric Urology|May 26, 2026
Prognostic outcomes of multifocal bilateral Wilms tumor: A Chinese multicenter cohort studyJing-Hao Yan, Xiao-Feng Chang, Kui-Ran Dong, et al.
Biorxiv : the Preprint Server for Biology|August 12, 2025
Humanized mice enable in vivo evaluation of engineered plasma cell biology and therapeutic functionTyler F Hill, Anna E Helmers, Rene Yu-Hong Cheng, et al.
Cell Reports. Medicine|July 25, 2025
Multimodal analysis stratifies genetic susceptibility and reveals the pathogenic mechanism of kidney injury in diabetic nephropathySong Jiang, Hanying Jia, Qing Hou, et al.
Molecular Therapy. Advances|May 15, 2026
Humanized mice enable <i>in vivo</i> evaluation of engineered plasma cell biology and therapeutic functionTyler F Hill, Anna E Helmers, Rene Yu-Hong Cheng, et al.
Nature Communications|September 27, 2018
Author Correction: An intercross population study reveals genes associated with body size and plumage color in ducksZhengkui Zhou, Ming Li, Hong Cheng, et al.
Nature Communications|July 19, 2018
An intercross population study reveals genes associated with body size and plumage color in ducksZhengkui Zhou, Ming Li, Hong Cheng, et al.
Blood|July 10, 2014
PIM inhibitors target CD25-positive AML cells through concomitant suppression of STAT5 activation and degradation of MYC oncogeneZhuyan Guo, Anlai Wang, Weidong Zhang, et al.
Pageof 192